Overview

Thrombotic microangiopathies are characterized by microangiopathic hemolytic anemia, microvascular thrombosis, and thrombocytopenia. It is important to effectively differentiate these disorders that require urgent treatment. During this webcast, expert faculty describes diagnostic and management approaches for thrombotic thrombocytopenic purpura (TTP), atypical hemolytic uremic syndrome (aHUS), disseminated intravascular coagulopathy (DIC), and cancer and chemotherapy associated thrombotic microangiopathy.
 

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

1. Describe the initial approach to the patient with thrombotic microangiopathy (TMA)
2. Discuss how to effectively differentiate and diagnose TTP, aHUS, DIC, and cancer/chemotherapy associated TMA
3. Identify management strategies of TTP, aHUS, DIC, and cancer/chemotherapy associated TMA